Danaher Co. (NYSE:DHR – Free Report) – Leerink Partnrs raised their FY2024 earnings per share (EPS) estimates for Danaher in a research note issued on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now expects that the conglomerate will earn $7.52 per share for the year, up from their previous estimate of $7.49. The consensus estimate for Danaher’s current full-year earnings is $7.50 per share. Leerink Partnrs also issued estimates for Danaher’s Q4 2024 earnings at $2.18 EPS.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. During the same period in the prior year, the business earned $2.02 EPS. The business’s revenue for the quarter was up 3.1% on a year-over-year basis.
Get Our Latest Stock Report on DHR
Danaher Stock Up 0.6 %
DHR opened at $245.73 on Wednesday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The company has a market capitalization of $177.49 billion, a PE ratio of 46.90, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The business has a 50-day moving average of $234.90 and a 200-day moving average of $253.47. Danaher has a fifty-two week low of $225.42 and a fifty-two week high of $281.70.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the company. Wedge Capital Management L L P NC grew its stake in shares of Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after buying an additional 38 shares during the last quarter. Certified Advisory Corp boosted its holdings in shares of Danaher by 4.5% during the second quarter. Certified Advisory Corp now owns 926 shares of the conglomerate’s stock worth $231,000 after purchasing an additional 40 shares during the period. Meridian Financial Partners LLC boosted its holdings in shares of Danaher by 4.4% during the third quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock worth $266,000 after purchasing an additional 40 shares during the period. Kovack Advisors Inc. boosted its holdings in shares of Danaher by 3.4% during the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after purchasing an additional 41 shares during the period. Finally, Well Done LLC boosted its holdings in shares of Danaher by 1.2% during the third quarter. Well Done LLC now owns 3,551 shares of the conglomerate’s stock worth $987,000 after purchasing an additional 42 shares during the period. Institutional investors own 79.05% of the company’s stock.
Danaher Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s dividend payout ratio is presently 20.61%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.